These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9049187

  • 61. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.
    Vijayachandra K, Lee J, Glick AB.
    Cancer Res; 2003 Jul 01; 63(13):3447-52. PubMed ID: 12839923
    [Abstract] [Full Text] [Related]

  • 62. TGFbeta isoforms and decorin gene expression are modified in fibroblasts obtained from non-syndromic cleft lip and palate subjects.
    Bodo M, Baroni T, Carinci F, Becchetti E, Bellucci C, Pezzetti F, Conte C, Evangelisti R, Carinci P.
    J Dent Res; 1999 Dec 01; 78(12):1783-90. PubMed ID: 10598907
    [Abstract] [Full Text] [Related]

  • 63. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis.
    Gebhardt C, Breitenbach U, Tuckermann JP, Dittrich BT, Richter KH, Angel P.
    Oncogene; 2002 Jun 20; 21(27):4266-76. PubMed ID: 12082614
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Differential induction of Cyp1a1, Cyp1b1, Ahd4, and Nmo1 in murine skin tumors and adjacent normal epidermis by ligands of the aryl hydrocarbon receptor.
    Reiners JJ, Jones CL, Hong N, Myrand SP.
    Mol Carcinog; 1998 Feb 20; 21(2):135-46. PubMed ID: 9496914
    [Abstract] [Full Text] [Related]

  • 71. Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures.
    McAnulty RJ, Hernández-Rodriguez NA, Mutsaers SE, Coker RK, Laurent GJ.
    Biochem J; 1997 Feb 01; 321 ( Pt 3)(Pt 3):639-43. PubMed ID: 9032448
    [Abstract] [Full Text] [Related]

  • 72. Changes in the expression of TGFbeta-isoforms in the anterior pituitary during withdrawal and resumption of feeding in hens.
    Chowdhury VS, Nishibori M, Yoshimura Y.
    Gen Comp Endocrinol; 2003 Aug 01; 133(1):1-7. PubMed ID: 12899841
    [Abstract] [Full Text] [Related]

  • 73. Expression, purification and characterization of BG(E)RII: a novel pan-TGFbeta inhibitor.
    Verona EV, Tang Y, Millstead TK, Hinck AP, Agyin JK, Sun LZ.
    Protein Eng Des Sel; 2008 Jul 01; 21(7):463-73. PubMed ID: 18499679
    [Abstract] [Full Text] [Related]

  • 74. Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin.
    Berger F, Geddert H, Faller G, Werner M, Dimmler A.
    Pathol Res Pract; 2014 Sep 01; 210(9):596-602. PubMed ID: 24954139
    [Abstract] [Full Text] [Related]

  • 75. Regulation by adrenocorticotropin (ACTH), angiotensin II, transforming growth factor-beta, and insulin-like growth factor I of bovine adrenal cell steroidogenic capacity and expression of ACTH receptor, steroidogenic acute regulatory protein, cytochrome P450c17, and 3beta-hydroxysteroid dehydrogenase.
    Le Roy C, Li JY, Stocco DM, Langlois D, Saez JM.
    Endocrinology; 2000 May 01; 141(5):1599-607. PubMed ID: 10803567
    [Abstract] [Full Text] [Related]

  • 76. Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis.
    Stepp MA, Pal-Ghosh S, Tadvalkar G, Rajjoub L, Jurjus RA, Gerdes M, Ryscavage A, Cataisson C, Shukla A, Yuspa SH.
    Mol Carcinog; 2010 Apr 01; 49(4):363-73. PubMed ID: 20082322
    [Abstract] [Full Text] [Related]

  • 77. TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart.
    Boyer AS, Ayerinskas II, Vincent EB, McKinney LA, Weeks DL, Runyan RB.
    Dev Biol; 1999 Apr 15; 208(2):530-45. PubMed ID: 10191064
    [Abstract] [Full Text] [Related]

  • 78. Transforming growth factor-beta and prostate cancer.
    Steiner MS.
    World J Urol; 1995 Apr 15; 13(6):329-36. PubMed ID: 9116751
    [Abstract] [Full Text] [Related]

  • 79. Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen.
    Dallas SL, Zhao S, Cramer SD, Chen Z, Peehl DM, Bonewald LF.
    J Cell Physiol; 2005 Feb 15; 202(2):361-70. PubMed ID: 15389580
    [Abstract] [Full Text] [Related]

  • 80. Expression of transforming growth factor beta1 and its receptors in normal human urothelium and human transitional cell carcinomas.
    Izadifar V, de Boer WI, Muscatelli-Groux B, Maillé P, van der Kwast TH, Chopin DK.
    Hum Pathol; 1999 Apr 15; 30(4):372-7. PubMed ID: 10208456
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.